Protocol No.: 25-085-NCP

SIGNAL-ER 101: Signatera-Guided Initiation of Adjuvant CDK4/6 Inhibitor in Intermediate Risk HR+ HER2- Breast Cancer
Principal Investigator
Jiang, Bei
Phase
II
Age Group
Adult
Applicable Disease Site
Breast Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Kaitlyn Hager
Research Nurse

View on ClinicalTrials.gov